Related Experiment Video

Updated: Apr 28, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.1K

Quantity and accessibility for specific targeting of receptors in tumours

Sajid Hussain1, Maria Rodriguez-Fernandez2, Gary B Braun1

  • 11] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Center for Nanomedicine, and Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA 93106-9610, USA.

Scientific Reports
|June 11, 2014
PubMed

Insights

Ligand-directed drug targeting shows promise for solid tumors, but receptor availability remains a challenge. Enhancing drug delivery to tumors is crucial for improving therapeutic efficacy.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Ligand-directed drug targeting is a promising strategy for cancer therapy, especially for solid tumors.
  • Current successes are mainly in blood-borne cancers, with limited advances in solid tumors.

Purpose of the Study:

  • To investigate receptor number and availability as critical factors in ligand-directed drug targeting for solid tumors.
  • To evaluate the impact of a tumor-penetrating peptide on receptor availability and overall targeting efficacy.

Main Methods:

  • Quantification and assessment of receptor availability for two targeting ligands in solid tumors.
  • Utilized a tumor-penetrating peptide to enhance drug transport to extravascular tumor tissues.
  • Developed mathematical models to analyze targeting mechanisms and predict efficacy.

Main Results:

  • Both the low number of receptors and their limited availability are significant obstacles in drug targeting.
  • A tumor-penetrating peptide improved receptor availability but did not overcome the limitation of low receptor numbers.
  • High specific activity of drugs is essential to prevent exceeding receptor capacity and losing the targeting advantage.

Conclusions:

  • Receptor availability and number are critical bottlenecks for effective ligand-directed drug targeting in solid tumors.
  • While tumor-penetrating peptides can improve drug delivery, targeting efficacy is still constrained by receptor limitations.
  • Mathematical modeling can guide the optimization of drug targeting strategies by identifying key factors influencing efficacy.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

4.9K
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues10:36

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

7.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
596